Disrupting SARS-CoV-2 Spike Protein Activity: A Virtual Screening and Binding Assay Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms26010151 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Luís Queirós-Reis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, Portugal. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antiviral Agents. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EEA Grants/Norway, Fundação para a Ciência e Tecnologia.
Abstract (Originalsprache)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a respiratory virus that emerged in late 2019 and rapidly spread worldwide, causing the COVID-19 pandemic. The spike glycoprotein (S protein) plays a crucial role in viral target recognition and entry by interacting with angiotensin, converting enzyme 2 (ACE2), the functional receptor for the virus, via its receptor binding domain (RBD). The RBD availability for this interaction can be influenced by external factors, such as fatty acids. Linoleic acid (LA), a free fatty acid, has been shown to bind the S protein, modulating the viral infection by reducing initial target recognition. LA interacts with the fatty acid binding pocket (FABP), a potential drug target against SARS-CoV-2. In this study, we aimed to exploit the FABP as a drug target by performing a docking-based virtual screening with a library of commercially available, drug-like compounds. The virtual hits identified were then assessed in in vitro assays for the inhibition of the virus–host interaction and cytotoxicity. Binding assays targeting the spike–ACE2 interaction identified multiple compounds with inhibitory activity and low cytotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, Portugal.
- Animal Science Study Centre (CECA), University of Porto Agroenvironment, Technologies and Sciences Institute (ICETA), 4051-401 Porto, Portugal.
- Associate Laboratory for Animal and Veterinary Science (AL4AnimalS), 1300-477 Lisboa, Portugal.
- Advanced Polytechnic and University Cooperative, University Institute of Health Sciences (CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra, Portugal.
- Department of Organic Chemistry, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
- School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff CF10 3BN, UK.
ORCID-Profile: Ana Colette Maurício, Andrea Brancale, João R Mesquita
Förderung
- EEA Grants/Norway
- Fundação para a Ciência e Tecnologia
Zitieren
APA
Queirós-Reis, L., Alvites, R., Maurício, A. C., Brancale, A., Bassetto, M., & Mesquita, J. R. (2024). Disrupting SARS-CoV-2 Spike Protein Activity: A Virtual Screening and Binding Assay Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010151
Vancouver
Queirós-Reis L, Alvites R, Maurício AC, Brancale A, Bassetto M, Mesquita JR. Disrupting SARS-CoV-2 Spike Protein Activity: A Virtual Screening and Binding Assay Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010151
BibTeX
@article{QueirsReis2024,
author = {Queirós-Reis, Luís and Alvites, Rui and Maurício, Ana Colette and Brancale, Andrea and Bassetto, Marcella and Mesquita, João R},
title = {Disrupting SARS-CoV-2 Spike Protein Activity: A Virtual Screening and Binding Assay Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms26010151}
}
EUVIMED